Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Tuberculosis (Edinburgh, Scotland)
|
July 14, 2012
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
Ekaterina V Kurbatova, Allison Taylor, Victoria M Gammino, et al.
The Lancet. Infectious Diseases
|
March 28, 2013
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action
William A Wells, Catharina C Boehme, Frank G J Cobelens, et al.
Plos Medicine
|
January 22, 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
Anna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, et al.
Plos Medicine
|
January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
Allison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
The Lancet. Global Health
|
March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
Rebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.
The Lancet. Infectious Diseases
|
April 17, 2025
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
Hatim Sati, Elena Carrara, Alessia Savoldi, et al.
The Lancet. Respiratory Medicine
|
November 2, 2025
Climate change and tuberculosis: an analytical framework
Matthew J Saunders, Delia Boccia, Palwasha Y Khan, et al.
Vaccine
|
February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Sonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The Lancet. Microbe
|
April 4, 2022
The 2021 WHO catalogue of <i>Mycobacterium tuberculosis</i> complex mutations associated with drug resistance: A genotypic analysis
Timothy M Walker, Paolo Miotto, Claudio U Köser, et al.
Bulletin of the World Health Organization
|
November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimization
Ankur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Tuberculosis (Edinburgh, Scotland)
|
July 14, 2012
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
Ekaterina V Kurbatova, Allison Taylor, Victoria M Gammino, et al.
The Lancet. Infectious Diseases
|
March 28, 2013
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action
William A Wells, Catharina C Boehme, Frank G J Cobelens, et al.
Plos Medicine
|
January 22, 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
Anna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, et al.
Plos Medicine
|
January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
Allison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
The Lancet. Global Health
|
March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
Rebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.
The Lancet. Infectious Diseases
|
April 17, 2025
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
Hatim Sati, Elena Carrara, Alessia Savoldi, et al.
The Lancet. Respiratory Medicine
|
November 2, 2025
Climate change and tuberculosis: an analytical framework
Matthew J Saunders, Delia Boccia, Palwasha Y Khan, et al.
Vaccine
|
February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Sonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The Lancet. Microbe
|
April 4, 2022
The 2021 WHO catalogue of <i>Mycobacterium tuberculosis</i> complex mutations associated with drug resistance: A genotypic analysis
Timothy M Walker, Paolo Miotto, Claudio U Köser, et al.
Bulletin of the World Health Organization
|
November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimization
Ankur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
Page
of 9